Optitorque
Payments companies reported to CMS as associated with Optitorque. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optitorque, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optitorque
These are the largest totals companies reported as associated with Optitorque. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Claudia Serrano-Gomez | New York, NY | Interventional Cardiology | $13,046.59 |
| Arun Kalyanasundaram | Marshfield, WI | Interventional Cardiology | $5,500.00 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $3,000.00 |
| Mitul Patel | San Diego, CA | Interventional Cardiology | $2,500.00 |
| Zola Ndandu | East Palatka, FL | Interventional Cardiology | $2,250.00 |
| Arnold Seto | Orange, CA | Interventional Cardiology | $2,200.00 |
| Hayder Hashim | Washington, DC | Cardiovascular Disease | $2,000.00 |
| Rhian Davies | York, PA | Cardiovascular Disease | $1,650.00 |
| Amir Kaki | Detroit, MI | Interventional Cardiology | $1,100.00 |
| Sameh Sayfo | Plano, TX | Interventional Cardiology | $1,100.00 |
Prescribed Optitorque?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.